BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

19686

544009

BLUEJET

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BLUE JET HEALTHCARE LTD performance

Today’s low

Today’s high

₹ 682.50 ₹ 730.10
₹ 711.15

52 week low

52 week high

₹ 347.60 ₹ 968.30
₹ 711.15

Open Price

₹ 698.00

Prev. Close

₹ 685.40

Volume (Shares)

654607.00

Total traded value

₹ 4655.23

Upper Circuit

₹ 753.90

Lower Circuit

₹ 616.90

info

BLUE JET HEALTHCARE LTD Share Price Update

As of the latest trading session, BLUE JET HEALTHCARE LTD share price is currently at ₹ 711.15, which is up by ₹ 25.75 from its previous closing. Today, the stock has fluctuated between ₹ 682.50 and ₹ 730.10. Over the past year, BLUE JET HEALTHCARE LTD has achieved a return of 83.38 %. In the last month alone, the return has been -15.39 %. Read More...

BLUE JET HEALTHCARE LTD fundamentals


  • Market cap (Cr)

    70.49

  • P/E Ratio (TTM)

    52.61

  • Beta

    1.47

  • Book Value / share

    53.26

  • Return on equity

    21.45%

  • EPS (TTM)

    13.53

  • Dividend yield

    0.14%

  • Net profit/quarter (Cr)

    98.98

info icon alternate text
  • Market cap (Cr)

    70.55

  • P/E Ratio (TTM)

    52.61

  • Beta

    1.39

  • Book Value / share

    53.26

  • Return on equity

    21.45%

  • EPS (TTM)

    13.53

  • Dividend yield

    0.14%

  • Net profit/quarter (Cr)

    98.98

info icon alternate text

BLUE JET HEALTHCARE LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 318.38
Operating Expense 199.13
Net Profit 98.98
Net Profit Margin (%) 31.08
Earnings Per Share (EPS) 5.71
EBITDA 137.26
Effective Tax Rate (%) 25.29
Particulars SEP 2024 (Values in Cr)
Revenue 208.26
Operating Expense 143.41
Net Profit 58.35
Net Profit Margin (%) 28.01
Earnings Per Share (EPS) 3.36
EBITDA 81.56
Effective Tax Rate (%) 24.15
Particulars JUN 2024 (Values in Cr)
Revenue 162.90
Operating Expense 122.15
Net Profit 37.78
Net Profit Margin (%) 23.19
Earnings Per Share (EPS) 2.18
EBITDA 52.98
Effective Tax Rate (%) 23.63
Particulars MAR 2024 (Values in Cr)
Revenue 183.95
Operating Expense 138.63
Net Profit 39.65
Net Profit Margin (%) 21.55
Earnings Per Share (EPS) 2.29
EBITDA 61.90
Effective Tax Rate (%) 26.77
Particulars DEC 2023 (Values in Cr)
Revenue 166.76
Operating Expense 120.07
Net Profit 32.11
Net Profit Margin (%) 19.25
Earnings Per Share (EPS) 1.85
EBITDA 51.60
Effective Tax Rate (%) 26.52
Particulars MAR 2024 (Values in Cr)
Revenue 711.60
Operating Expense 510.62
Net Profit 163.75
Net Profit Margin (%) 23.01
Earnings Per Share (EPS) 9.44
EBITDA 248.35
Effective Tax Rate (%) 25.59
Particulars MAR 2023 (Values in Cr)
Revenue 720.98
Operating Expense 528.33
Net Profit 160.03
Net Profit Margin (%) 22.19
Earnings Per Share (EPS) 9.23
EBITDA 243.04
Effective Tax Rate (%) 26.12
Particulars MAR 2022 (Values in Cr)
Revenue 683.47
Operating Expense 459.65
Net Profit 181.59
Net Profit Margin (%) 26.56
Earnings Per Share (EPS) 10.47
EBITDA 268.68
Effective Tax Rate (%) 25.34
Particulars MAR 2021 (Values in Cr)
Revenue 498.93
Operating Expense 317.23
Net Profit 141.62
Net Profit Margin (%) 28.38
Earnings Per Share (EPS) 1428.57
EBITDA 215.46
Effective Tax Rate (%) 25.65
Particulars MAR 2020 (Values in Cr)
Revenue 538.20
Operating Expense 350.03
Net Profit 144.71
Net Profit Margin (%) 26.88
Earnings Per Share (EPS) 1461.22
EBITDA 219.29
Effective Tax Rate (%) 25.36
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3332.27
ROE % 50.18
ROCE % 55.94
Total Debt to Total Equity 0.24
EBITDA Margin 42.02
Particulars MAR 2020 (Values in Cr)
Book Value / Share 30430.17
ROE % 71.97
ROCE % 71.21
Total Debt to Total Equity 0.39
EBITDA Margin 40.79
Particulars MAR 2024 (Values in Cr)
Book Value / Share 48.73
ROE % 21.45
ROCE % 28.55
Total Debt to Total Equity 0.01
EBITDA Margin 34.90
Particulars MAR 2023 (Values in Cr)
Book Value / Share 39.29
ROE % 26.60
ROCE % 35.31
Total Debt to Total Equity 0.02
EBITDA Margin 33.71
Particulars MAR 2022 (Values in Cr)
Book Value / Share 30.07
ROE % 42.16
ROCE % 52.43
Total Debt to Total Equity 0.08
EBITDA Margin 39.31
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1371.58
ROE % 52.64
ROCE % 58.36
Total Debt to Total Equity 0.23
EBITDA Margin 43.18
Particulars MAR 2020 (Values in Cr)
Book Value / Share 31483.17
ROE % 73.01
ROCE % 73.25
Total Debt to Total Equity 0.37
EBITDA Margin 40.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 70.45
Total Assets 536.27
Total Liabilities 536.27
Total Equity 339.81
Share Outstanding 991231
Price to Book Ratio 0.00
Return on Assets (%) 25.81
Return on Capital (%) 35.37
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 15.22
Total Assets 375.39
Total Liabilities 375.39
Total Equity 202.74
Share Outstanding 60000
Price to Book Ratio 0.00
Return on Assets (%) 38.58
Return on Capital (%) 51.67
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 84.70
Total Assets 1058.84
Total Liabilities 1058.84
Total Equity 845.22
Share Outstanding 173465425
Price to Book Ratio 7.85
Return on Assets (%) 15.46
Return on Capital (%) 19.37
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 65.63
Total Assets 862.06
Total Liabilities 862.06
Total Equity 681.48
Share Outstanding 173465425
Price to Book Ratio 0.00
Return on Assets (%) 18.56
Return on Capital (%) 23.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 87.66
Total Assets 713.37
Total Liabilities 713.37
Total Equity 521.54
Share Outstanding 173465425
Price to Book Ratio 0.00
Return on Assets (%) 25.45
Return on Capital (%) 34.82
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 70.45
Total Assets 533.56
Total Liabilities 533.56
Total Equity 339.81
Share Outstanding 991231
Price to Book Ratio 0.00
Return on Assets (%) 26.54
Return on Capital (%) 37.7
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 15.20
Total Assets 364.23
Total Liabilities 364.23
Total Equity 198.21
Share Outstanding 60000
Price to Book Ratio 0.00
Return on Assets (%) 39.73
Return on Capital (%) 58.01
Particulars MAR 2021 (Values in Cr)
Net Income 184.65
Cash from Operations 129.47
Cash from Investing -50.72
Cash from Financing -27.49
Net change in Cash 51.05
Free Cash Flow 161.58
Particulars MAR 2020 (Values in Cr)
Net Income 194.12
Cash from Operations 171.35
Cash from Investing -45.23
Cash from Financing -72.49
Net change in Cash 4.99
Free Cash Flow 187.37
Particulars MAR 2024 (Values in Cr)
Net Income 220.09
Cash from Operations 252.34
Cash from Investing -263.75
Cash from Financing -1.98
Net change in Cash -24.48
Free Cash Flow 425.20
Particulars MAR 2023 (Values in Cr)
Net Income 216.61
Cash from Operations 201.53
Cash from Investing -147.25
Cash from Financing -4.23
Net change in Cash -9.93
Free Cash Flow 260.80
Particulars MAR 2022 (Values in Cr)
Net Income 243.23
Cash from Operations 174.00
Cash from Investing -76.02
Cash from Financing -56.14
Net change in Cash 14.24
Free Cash Flow 195.79
Particulars MAR 2021 (Values in Cr)
Net Income 190.48
Cash from Operations 136.98
Cash from Investing -60.98
Cash from Financing -20.54
Net change in Cash 55.25
Free Cash Flow 171.94
Particulars MAR 2020 (Values in Cr)
Net Income 193.88
Cash from Operations 171.02
Cash from Investing -45.23
Cash from Financing -72.50
Net change in Cash 4.65
Free Cash Flow 187.04
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

BLUE JET HEALTHCARE LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
711.15 3.75 redarrow
red-green-graph indicator
12 Bearish
4 Bullish
  • 5 Days 714.40
  • 26 Days 752.40
  • 10 Days 724.80
  • 50 Days 752.80
  • 12 Days 729.00
  • 100 Days 705.80
  • 20 Days 744.70
  • 200 Days 621.10
696.62 PIVOT

First Support

668.78

First Resistance

713.23

Second Support

652.17

Second Resistance

741.07

Third Support

624.33

Third Resistance

757.68

RSI

43.92

ADX

26.82

MACD

-23.45

Williams % R

-46.32

Commodity Channel Index (CCI)

-54.78

Date

2025-04-30

Week

206145.00

Same Day

244128.00

Month

272218.00

1 Year

1.47

3 Year

1.28

Over 1 Month

-15.39%

down

Over 1 Year

83.38%

down

Over 3 Months

2.58%

down

Over 3 Years

0.00%

down

Over 6 Months

48.68%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

BLUE JET HEALTHCARE LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
10.38%
Promoter Holdings
86.0%
FII
2.28%
DII
1.33%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Akshay Bansarilal Arora 1.19670324E8 (68.99%) Shareholding of Promoter and Promoter Group
Shiven Akshay Arora 1.9009901E7 (10.96%) Shareholding of Promoter and Promoter Group
Archana Akshay Arora 1.05E7 (6.05%) Shareholding of Promoter and Promoter Group
Anisha Juneja 10.0 (0.0%) Shareholding of Promoter and Promoter Group
Amit Dhawan 10.0 (0.0%) Shareholding of Promoter and Promoter Group
Alka Rakesh Bakshi 10.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

BLUE JET HEALTHCARE LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

BLUE JET HEALTHCARE LTD Share Price

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968. The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai. Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022.

The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It has operations organized into three product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). It is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare products.

Since incorporation in 1968, the Company was established with the name Jet Chemicals Private Limited' in Shahad (Unit I) by Late Shri B L Arora. At present, Company has been expanded to include contract development and manufacturing organization (CDMO) business model with specialized chemistry capabilities in contrast media intermediates and high intensity.

In 1970, the Company began manufacturing saccharin and its salts, which are high-intensity sweeteners.
In 2000, it entered the X-ray contrast media sector, with a basic building block (5- NIPA).
In 2002, it started manufacturing of pharma intermediates and API.
In 2003, it established Blue Circle Organics Private Limited at their Unit-II, Ambernath facility.
In 2017, it started semi-automated manufacturing block for their contrast media intermediate business.

The National Company Law Tribunal at Mumbai (NCLT), by way of its Order dated November 19, 2020, sanctioned a Scheme of Merger amongst the Company, Blue Circle Organics Private Limited and their respective shareholders, and creditors and made it effective from December 28, 2020.

In 2020 it acquired a Unit III brownfield site in Mahad.

In 2021, it acquired a Unit IV 'greenfield' manufacturing site in Ambernath.

The Company made an Offer for Sale of issuing 24,285,160 Equity Shares of Rs 2/- each by raising funds aggregating to Rs 84 Crore in October, 2023.

In 2024, Company launched a new product in the PI/API division for a cardiovascular innovator, with rise in pharmacy benefits.

Parent organization Indian Private
NSE symbol BLUEJET
Founded 1968
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Blue Jet Healthcare Ltd?

Answer Field

The share price of Blue Jet Healthcare Ltd for NSE is ₹ 711.15 and for BSE is ₹ 711.75.

What is the Market Cap of Blue Jet Healthcare Ltd?

Answer Field

The market cap of Blue Jet Healthcare Ltd for NSE is ₹ 70.49 Cr. and for BSE is ₹ 70.55 Cr. as of now.

What is the 52 Week High and Low of Blue Jet Healthcare Ltd?

Answer Field

The 52 Week High and Low of Blue Jet Healthcare Ltd for NSE is ₹ 968.30 and ₹ 347.60 and for BSE is ₹ 968.75 and ₹ 346.70.

How to Buy Blue Jet Healthcare Ltd share?

Answer Field

You can trade in Blue Jet Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Blue Jet Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 83.38%.

What is the Current Share Price of Blue Jet Healthcare Ltd?

Answer Field

Blue Jet Healthcare Ltd share price is for NSE ₹ 711.15 & for BSE ₹ 711.75 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Blue Jet Healthcare Ltd Share?

Answer Field

The market cap of Blue Jet Healthcare Ltd for NSE ₹ 70.49 & for BSE ₹ 70.55 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Blue Jet Healthcare Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Blue Jet Healthcare Ltd share is 52.61.

What is the PB ratio of Blue Jet Healthcare Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Blue Jet Healthcare Ltd share is 53.26.

How to Buy Blue Jet Healthcare Ltd Share?

Answer Field

You can trade in Blue Jet Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Blue Jet Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Blue Jet Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Blue Jet Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|